Charles B. Malpas

Oct 15, 2024 | medrxiv.org | Roxane Dilcher |Charles B. Malpas |William O'Brien |Stuart Mcdonald

Conflict of Interest Disclosures: TOB reported receiving consulting fees to the institution from UCB, Livanova, GSK, and Eisai outside the submitted work. LV reported receiving consulting fees from Steminent Biotherapeutics outside the submitted work. No other disclosures were reported. ACTRN12620001254987This study was funded by a Medical Research Future Fund grant from the Australian Government to TOB and LV (MRF1200254).

Oct 6, 2024 | alz-journals.onlinelibrary.wiley.com | Dhamidhu Eratne |Courtney Lewis |Christa Dang |Charles B. Malpas

1 INTRODUCTION Despite major improvements in clinical assessment, many patients with neurodegenerative disorders (ND) still face significant barriers and challenges to timely, accurate diagnosis; delays often last several years even with gold-standard assessments.1 These challenges are worse for younger people (onset of symptoms < 60–65 years of age), where a wider range of ND and less typical presentations of ND are more common, and substantial overlap in symptoms with psychiatric disorders...

Jul 21, 2023 | journals.sagepub.com | Dhamidhu Eratne |Matthew Kang |Charles B. Malpas |Steve Simpson-Yap

Cite articleCite articleIf you have citation software installed, you can download article citation data to the citation manager of your choiceSelect your citation manager software:Metrics and citationsMetricsTotal views and downloads:0*Article usage tracking started in December 2016 Receive email alerts when this article is citedWeb of Science: 0Crossref: 0There are no citing articles to show.